Paper
海绵种类未注明
Design, fabrication, and evaluation of antimicrobial sponge-hydrogel bilayer microneedles: An integrated system for transdermal insulin delivery and glucose sensing
- Drug Delivery
- 2026
Key Summary (10 Points)
- 1
Diabetes mellitus is a chronic metabolic disorder requiring long-term management, as persistent hyperglycemia can lead to severe complications, making real-time glucose monitoring and precise blood glucose control essential.
- 2
Traditional subcutaneous insulin injections are inconvenient, exhibit poor patient compliance and dosing accuracy, and lack real-time feedback, which hinders personalized therapy.
- 3
Microneedles offer a minimally invasive, user-friendly, and self-administered alternative to conventional insulin delivery methods.
- 4
Existing microneedle systems exhibit limitations including low drug-loading capacity, insufficient controlled-release performance, lack of glucose-monitoring capability, and inherent infection risks that restrict their application in long-term diabetes management.
- 5
Researchers developed a novel antimicrobial sponge-hydrogel bilayer microneedle system (ASMNs@PVA/SA-INS) that integrates insulin delivery, glucose sensing, and antimicrobial protection.
- 6
The system comprises a polyvinyl alcohol/sodium alginate (PVA/SA) hydrogel layer for controlled insulin release and a sponge microneedle base functionalized with silver nanoparticles to provide antibacterial activity.
- 7
Experimental results demonstrated that over 83% of insulin was released within 24 hours, effectively controlling blood glucose for more than 8 hours.
- 8
The system responded to glucose level changes within 10 minutes through a visible color change, indicating real-time glucose sensing capability.
- 9
This integrated platform offers a promising strategy for intelligent and personalized diabetes management.
- 10
The multifunctional system demonstrates the potential of next-generation medical devices that simultaneously perform drug delivery, disease monitoring, and infection prevention.
摘要 (Abstract)
原文照录自出处。可通过上方链接阅读全文。
Diabetes mellitus is a chronic metabolic disorder that requires long-term management, as persistent hyperglycemia may lead to severe complications, thereby making real-time glucose monitoring and precise control essential. Traditional subcutaneous insulin injections are inconvenient, exhibit poor patient compliance and dosing accuracy, and do not provide real-time feedback, thereby hindering personalized therapy. Microneedles (MNs) offers a minimally invasive, user-friendly, and self-administered alternative; however, existing MN systems still exhibit low drug-loading capacity, insufficient controlled-release performance, a lack of glucose-monitoring capability, and inherent infection risks, which limit their application in long-term diabetes management. To address these limitations, we developed a novel antimicrobial sponge-hydrogel bilayer MNs system (ASMNs@PVA/SA-INS) that integrates insulin delivery, glucose sensing, and antimicrobial protection. The system comprises a polyvinyl alcohol/sodium alginate (PVA/SA) hydrogel layer for controlled insulin release and a sponge MN base functionalized silver nanoparticles to provide antibacterial activity. Experiments results demonstrated that over 83 % of insulin was released within 24 h, effectively controlling blood glucose for more than 8 h. Additionally, the system responded to glucose level changes within 10 min through a visible color change, indicating real-time sensing capability. This platform offers a promising strategy for intelligent and individualized diabetes management.
Keywords
Citation
Zhang X, Zheng H, Zhang Y, Yang X, Jin N, Zhang Q, Chen J (2026). Design, fabrication, and evaluation of antimicrobial sponge-hydrogel bilayer microneedles: An integrated system for transdermal insulin delivery and glucose sensing. Biomaterials advances. https://doi.org/10.1016/j.bioadv.2025.214693